- Home
- RNST vs RNA Comparison
RNST vs RNA Comparison
Compare RNST & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNST
- RNA
- Stock Information
- Founded
- RNST 1904
- RNA 2012
- Country
- RNST United States
- RNA United States
- Employees
- RNST N/A
- RNA N/A
- Industry
- RNST Major Banks
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- RNST Finance
- RNA Health Care
- Exchange
- RNST Nasdaq
- RNA Nasdaq
- Market Cap
- RNST 3.7B
- RNA 4.0B
- IPO Year
- RNST N/A
- RNA 2020
- Fundamental
- Price
- RNST $34.18
- RNA $69.79
- Analyst Decision
- RNST Strong Buy
- RNA Buy
- Analyst Count
- RNST 6
- RNA 20
- Target Price
- RNST $43.17
- RNA $69.26
- AVG Volume (30 Days)
- RNST 579.7K
- RNA 9.6M
- Earning Date
- RNST 10-28-2025
- RNA 11-07-2025
- Dividend Yield
- RNST 2.59%
- RNA N/A
- EPS Growth
- RNST N/A
- RNA N/A
- EPS
- RNST 1.84
- RNA N/A
- Revenue
- RNST $775,365,000.00
- RNA $10,729,000.00
- Revenue This Year
- RNST $42.94
- RNA N/A
- Revenue Next Year
- RNST $12.57
- RNA $108.97
- P/E Ratio
- RNST $18.53
- RNA N/A
- Revenue Growth
- RNST 13.05
- RNA 1.23
- 52 Week Low
- RNST $26.97
- RNA $21.51
- 52 Week High
- RNST $40.40
- RNA $70.51
- Technical
- Relative Strength Index (RSI)
- RNST 42.05
- RNA 79.32
- Support Level
- RNST $33.04
- RNA $69.50
- Resistance Level
- RNST $34.68
- RNA $69.91
- Average True Range (ATR)
- RNST 0.81
- RNA 1.03
- MACD
- RNST 0.05
- RNA 1.12
- Stochastic Oscillator
- RNST 43.02
- RNA 91.21
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.